BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23751593)

  • 1. Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?
    Süer E; Özcan C; Baltacı S; Gülpınar Ö; Burgu B; Haliloğlu A; Bedük Y
    Urol Int; 2013; 91(2):182-6. PubMed ID: 23751593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor.
    Lee SE; Jeong IG; Ku JH; Kwak C; Lee E; Jeong JS
    Urology; 2004 May; 63(5):873-7; discussion 877. PubMed ID: 15134968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of residual tumors at repeat transurethral resection in patients with T1 bladder cancer].
    Chen JC; Li T; Ning XH; Peng SH; Wang JY; Qi NN; Cai L; Gong K
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1124-7. PubMed ID: 27095782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy.
    Dwivedi US; Kumar A; Das SK; Trivedi S; Kumar M; Sunder S; Singh PB
    Urol Oncol; 2009; 27(5):514-9. PubMed ID: 18639472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
    Ayati M; Amini E; Shahrokhi Damavand R; Nowroozi MR; Soleimani M; Ranjbar E; Nowroozi A
    Urol J; 2019 May; 16(2):152-156. PubMed ID: 30251745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
    Shim JS; Choi H; Noh TI; Tae JH; Yoon SG; Kang SH; Bae JH; Park HS; Park JY
    Korean J Urol; 2015 Jun; 56(6):429-34. PubMed ID: 26078839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
    Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH
    PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
    Tseng WH; Liu CL; Huang SK; Liao AC; Kuo JR; Hun SH; Chen CH; Su CC; Wang JC; Lee KH; Shen KH; Li CF
    Int Urol Nephrol; 2019 Aug; 51(8):1335-1342. PubMed ID: 31129781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.
    Shoshany O; Mano R; Margel D; Baniel J; Yossepowitch O
    Urol Oncol; 2014 Jan; 32(1):40.e17-22. PubMed ID: 23911682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?
    Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H
    J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].
    Lazica DA; Böttcher S; Degener S; von Rundstedt FC; Brandt AS; Roth S; Störkel S; Mathers MJ
    Aktuelle Urol; 2013 Mar; 44(2):124-8. PubMed ID: 23580383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience.
    Rouprêt M; Yates DR; Varinot J; Phé V; Chartier-Kastler E; Bitker MO; Compérat E
    Can J Urol; 2012 Oct; 19(5):6459-64. PubMed ID: 23040628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?
    Minardi D; Milanese G; Parri G; Lacetera V; Muzzonigro G
    Arch Ital Urol Androl; 2016 Mar; 88(1):13-6. PubMed ID: 27072170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.